Pediatric cinnarizine overdose and toxicokinetics

Pediatrics
Dan TurnerYedidia Bentur

Abstract

Cinnarizine, a piperazine derivative, is a widely prescribed medication for the treatment of vestibular disorders and motion sickness. Cinnarizine has antihistaminic, antiserotoninergic, antidopaminergic, and calcium channel-blocking properties. We present the first report in the English literature of cinnarizine poisoning and toxicokinetics. A 30-month-old toddler ingested 225 mg of cinnarizine, 18 times the recommended dose for older children. Four hours later, she became jittery with a wide-based gait and vomited 3 times. She was examined by her family physician, who reported stupor and twitching in both hands. On admission to the hospital, 6 hours after the ingestion, she was stuporous and had 3 short, generalized tonic-clonic convulsions that were controlled with a single dose of midazolam. Full clinical recovery was seen 10 hours after ingestion. Serum cinnarizine levels were 7407, 2629, and 711 ng/mL on admission and at 4 and 12 hours thereafter, respectively, 26.9 times higher than the therapeutic levels in adults. Elimination rate constant, calculated by linear regression of the ln concentrations of the 3 data points, was 0.19. Half-life, calculated from the equation t(1/2) = 0.693/kel, where kel is the elimination rat...Continue Reading

References

Dec 1, 1990·BMJ : British Medical Journal·S F MossJ R Walker
Jan 30, 1987·The American Journal of Cardiology·T Godfraind
Jun 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·J F Martí MassóJ M Martínez-Lage
May 1, 1987·Neurology·F MicheliR Giannaula
May 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·F E Simons
Nov 1, 1993·The American Journal of Emergency Medicine·K R OlsonP D Blanc
Oct 1, 1995·Clinical Neuropharmacology·M A MenaJ Garcia de Yébenes
Jan 1, 1997·Clinical and Experimental Pharmacology & Physiology·E O Okoro, J F Marwood
Feb 24, 1999·Neuropediatrics·A YasuharaY Kobayashi
Feb 24, 2001·Human & Experimental Toxicology·D RadovanovicH Kupferschmidt

❮ Previous
Next ❯

Citations

Sep 14, 2014·European Journal of Clinical Pharmacology·Riccardo DavanzoGiulia Facchina
Mar 24, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bao-Qiu LiYong Wang
Feb 3, 2016·Drug Delivery and Translational Research·Hussein O AmmarAlaa H Salama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.